Zai Lab Investor:Zai Lab Investor Day 2023
Zai Lab Investor Day 2023
EventDetails.ZaiLabInvestorDay2023.Jun20,2023from9:00AMto12:00PMEDT.ClickheretovisittheZaiLabInvestorDay2023Microsite.。其他文章還包含有:「Investor&MediaContacts」、「PressReleases」、「Webcasts&Presentations」、「ZaiLab」、「ZaiLabAnnouncesParticipationinSeptemberInvestor...」、「ZaiLabAnnouncesUpcomingPresentationsinJuneInvestor...」、「ZaiLabLimited」、「ZaiLabLtdStockPriceToday」、「投資...
查看更多 離開網站Investor & Media Contacts
https://ir.zailaboratory.com
Investor Inquiries: Christine Chiou, SVP, Head of Investor Relations +1 (917) 886-6929 [email protected]
Press Releases
https://ir.zailaboratory.com
Zai Lab to present preliminary data from Phase 1 trial of ZL-1218, an investigational anti-CCR8 antibody for the treatment of advanced solid tumors.
Webcasts & Presentations
https://ir.zailaboratory.com
Investor Overview; Stock Information. Stock Quote & Chart · Historical Lookup · Analyst Coverage. Corporate Governance. Documents & Charters · Committee ...
Zai Lab
https://www.crunchbase.com
Zai Lab is an innovative biopharmaceutical company based in Shanghai focused on bringing transformative medicines for cancer, autoimmune and infectious diseases ...
Zai Lab Announces Participation in September Investor ...
https://finance.yahoo.com
Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that members of the Company's senior management team will participate in the following investor ...
Zai Lab Announces Upcoming Presentations in June Investor ...
https://zailab.gcs-web.com
Live webcasts of the conferences will be available under “Events & Presentations” in the “Investor Relations” section of Zai Lab's website. An archived replay ...
Zai Lab Limited
https://ir.zailaboratory.com
Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) is an innovative, research-based, commercial-stage biopharmaceutical company based in China and the United States.
Zai Lab Ltd Stock Price Today
https://www.investing.com
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience.
投資者概覽
https://ir.zailaboratory.com
再鼎醫藥(納斯達克股票代碼:ZLAB;香港聯交所股份代號:9688)是一家總部位於中國和美國、以研發為基礎、處於商業化階段的創新型生物製藥公司,專注於為中國及全球患者提供 ...